Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Kelie H. Luby

I first heard about Mint Medical in 2013 when a colleague said: ‘you have to see this software - this will change everything.’ At this time, I was part of the imaging Contract Research Organizations (iCROs) ecosystem, working in the area of imaging centrally read clinical trials, primarily in oncology. What my colleague and I realized was that mint Lesion™ allows you to ask for more.

Related Resources

Related Resources

New iRECIST Oncologic Response Criteria already in clinical use at the University Medical Center – Tübingen, Germany

Shortly following the release of the new iRECIST- oncologic response criteria (Lancet Oncology, March 2017) the University Medical Center in Tübingen,…

Mrs. Kelie Luby joins Mint Medical's team

Mrs. Kelie Luby will join Mint Medical’s team from January 2017 as new Vice President Clinical Trials Software and will be introduced at the upcoming…

Novel oncologic therapy response criteria (iRECIST and more)

Advances in oncology therapies, such as novel immune-related agents, require adapted and refined criteria and guidelines for the assessment and…